- $3.11bn
- $3.01bn
- $158.32m
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Liquidia falls after Q2 profit miss
Liquidia Corporation reports results for the quarter ended June 30 - Earnings Summary
Liquidia Q2 revenue jumps on YUTREPIA sales
Brief: Liquidia Q2 EPS USD 0.74 Vs. IBES Estimate USD 0.74
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Barrick Mining, Lumentum, Tesla
U.S. STOCKS ON THE MOVE-Moderna, Beazer Homes, Lumentum
Liquidia rises after co swings to Q1 profit
U.S. STOCKS ON THE MOVE-Liquidia, Target Hospitality, oil companies
Liquidia rises after co swings to Q1 profit
Liquidia Q1 EPS beats estimates as YUTREPIA sales drive profit
Brief: Liquidia Q1 EPS USD 0.52 Vs. IBES Estimate USD 0.41
Liquidia's 2025 EPS misses analyst expectations
Brief: Liquidia FY EPS USD -0.8 Vs. IBES Estimate USD -0.76
U.S. RESEARCH ROUNDUP- Cummins, Lockheed Martin, Moog
Pulmonary drug developer Liquidia posts operating profit in in first full quarter of YUTREPIA sales
Brief: Liquidia LIQUIDIA Q3 EPS USD -0.04 VS. IBES ESTIMATE USD -0.4